Lanxess in exclusive talks to acquire French biosecurity company
11:26 AM | January 11, 2021 | Sotirios Frantzanas
The value of the planned acquisition is estimated at just more than $85 million.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.